High-dose methotrexate with rituximab in patients with primary central nervous system lymphoma
Not Applicable
Recruiting
- Conditions
- primary central nervous system lymphoma
- Registration Number
- JPRN-UMIN000012602
- Lead Sponsor
- Department of Neurosurgery, Institute of Health Biosciences,The University of Tokushima Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
serum creatinine >1.3mg/dl, creatinine clearance <75ml/minute, white blood cell count <3000 per dL platelet count <100000 per dL positive for hepatitis B surface antigens, hepatitis C seropositivity pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival, progression-free survival, KPS
- Secondary Outcome Measures
Name Time Method